Anti-BrdUrd labeling of newly synthesized DNA in HL-60 cells triggered to apoptosis

Cytometry

Volumn 25, Issue 4, 1996, Pages 324-332

  Zamai, Loris ^a   Falcieri, Elisabetta ^b,c   Gobbi, Pietro ^a   Santi, Spartaco ^c   Falconi, Mirella ^c   Marhefka, Gregary ^a   Vitale, Marco ^c,d,e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c Ist Citomorfologia Normale P   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e Dipto Sci Biomediche Biotecnologie   (Italy)

Author keywords

Apoptosis; Bromodeoxyuridine; Camptothecin; Cell cycle; DNA synthesis

Indexed keywords

BROXURIDINE; CAMPTOTHECIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; APHIDICOLIN; APOPTOSIS; BROMODEOXYURIDINE; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; DNA, NEOPLASM; HL-60 CELLS; HUMANS; TIME FACTORS;

EID: 0029855527     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19961201)25:4<324::AID-CYTO3>3.3.CO;2-G     Document Type: Article

References (36)

1. Arends MJ, Morris RG, Wyllie AH: Apoptosis. The role of the endonuclease. AmJ Path 136:593-608, 1990.
2. Betrand R, Kerrigan O, Sarang M, Pommier Y: Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Biochem Pharmacol 42:77-85, 1991.
3. Catchpole DR, Stewart BW: Etoposide-induced cytotoxicity in two human T-cell leukemia lines: Delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res 53:4287-4296, 1993.
4. Cohen JJ: Programmed cell death in the immune system. Adv Immunol 50:55-85, 1991.
5. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hots MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808, 1992.
6. Del Bino G, Bruno S, Yi PN, Darzynkiewicz Z: Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Prolif 25:537-548, 1992.
7. Del Bino G, Lassota P, Darzynkiewicz Z: The S phase cytotoxicity of camptothecin. Exp Cell Res 193:27-35, 1991.
8. Del Bino G, Li X, Traganos F, Darzynkiewicz Z: Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs Leukemia 8:281-288, 1994.
9. Del Bino G, Skierski JS, Darzynkiewicz Z: Diverse effect of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG-1) leukemic cells. Cancer Res 50:5746-5750, 1990.
10. Del Bino G, Skierski JS, Darzynkiewicz Z: The concentration dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195:485-491, 1991.
11. Dolbeare F, Beisker W, Pallavicini MG, Vanderlaan M, Gray W: Cytochemistry of bromodeoxyuridine DNA analysis: Stoichiometry and sensitivity. Cytometry 6:521-530, 1985.
12. Ellis RE, Yuan J, Horvitz HR: Mechanisms and function of cell death. Annu Rev Cell Biol 7:663-698, 1991.
13. Gerschenson LE, Rotello RJ: Apoptosis: A different type of cell death. FASEB J 6:2450-2455, 1992.
14. 2+. Bioch Biophys Res Commun 181:915-920, 1991.
15. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z: The cell cycle related differences in susceptibility to apoptosis induced by various antitumor agents. Cancer Res 53:3186-3192, 1993.
16. Gorczyca W, Melamed MR, Darzynkiewicz Z: Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: Detection of DNA strand breaks by flow cytometry using the in situ nick translation assay. Toxicol Lett 67:249-258, 1993.
17. Holm C, Covey JM, Kerrigan D, Pommier, Y: Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in chinese hamster DC3F cells. Cancer Res 49: 6365-6368, 1989.
18. Hsiang Y-H, Hertzberg R, Hecht S Liu LF: Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873-14878, 1985.
19. Hsiang Y-H, Lihou MG, Liu LF: Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 49:5077-5082, 1989.
20. Kaufmann SH: Induction of endonucleolitic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49:5870-5878, 1989.
21. Kerr JFR, Wyllie AH, Curie AR: Apoptosis: A basic biological phenomenon with wide range implications in tissue kinetics. Br J Cancer 26:239-257, 1972.
22. Knab AM, Fertala J, Bjornsti M-A: Mechanisms of camptothecin resistance in yeast DNA to i mutants. J Biol Chem 268:22322-22330, 1993.
23. Liu LF: DNA topoisomerase poisons as antitumor drugs. Ann Rev Biochem 58:351-375, 1989.
24. Mazzotti G, Rizzoli R, Galanzi A, Papa S, Vitale M, Falconi M, Neri LM, Zini N, Maraldi NM: High resolution detection of newly synthesized DNA by anti-bromodeoxyuridine antibodies identifies specific chromatin domains. J Histochem Cytochem 38:13-22, 1990.
25. Nelson WG, Kastan MB: DNA strand breaks: The DNA template alterations that trigger p53 dependent DNA damage response pathways. Mol Cell Biol 14:1815-1823, 1994.
26. Palitti F: Mechanism of induction of chromosomal aberrations by inhibitors of DNA topoisomerases. Environ Mol Mutagen 22:275-277, 1993.
27. Papa S, Vitale M, Mazzotti G, Rizzoli R, Falconi M, Bartoletti A, Manzoli FA: Gradient fractionation of cycling and resting cells monitored by BrdUrd incorporation. Histochemistry 89:241-245, 1988.
28. Rizzoli R, Baratta B, Maraldi NM, Falconi M, Galanzi A, Papa S, Vitale M, Rizzi E Manzoli L, Mazzotti G: DNA synthesis progression in 3T3 synchronized fibroblasts. A high resolution approach. Histochemistry 97:181-187, 1992.
29. Sen S, D'Incalci M: Apoptosis: Biochemical events and relevance to cancer chemotherapy. FEBS Lett 307:122-127, 1992.
30. Squires S, Ryan AJ, Strutt HL, Smith PJ, Johnson RT: Deoxyguanosine enhances the cytotoxicity of the topoisomerase I inhibitor camptothecin by reducing the repair of double strand breaks. J Cell Sci 100:883-893, 1991
31. Tsao YP, D'Arpa P, Liu LF: The involvement of active DNA synthesis in camptothecin induced G2 arrest: Altered regulation of p34cdc2/ cyclin B. Cancer Res 52:1823-1829, 1992.
32. Vitale M, Rizzoli R, Mazzotti G, Zamai L, Galanzi A, Rizzi E, Manzoli L, Matteucci S, Papa S: Characterization and cell cycle kinetics of hepatocytes during rat liver regeneration: In vivo BrdUrd incorporation analysed by flow cytometry and electron microscopy Cell Prolif 24:331-358, 1991.
33. Vitale M, Zamai L, Mazzotti G, Cataldi A, Falcieri E: Differential kinetics of propidium iodide uptake in apoptotic and necrotic thymocytes. Histochemlstry 100:223-229, 1993.
34. William JT: Programmed cell death: Apoptosis and oncogenes. Cell 65:1097-1098, 1991
35. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. In: International Review of Cytology, vol. 68, Bourne GH, Danielli FJ, Jeon KW (eds). Academic Press, New York, 1980, pp 251-306.
36. Yoshida A, Ueda T, Wano Y, Nakamura T: DNA damage and killing by camptothecin and its derivative in human leukemia HL-60 cells. Jap Cancer Res 84:566-573, 1993.